Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study.
Saved in:
| Title: | Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study. |
|---|---|
| Authors: | Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: dshong@mdanderson.org., Bauer TM; Medical Oncology, Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, USA., Lee JJ; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA., Dowlati A; Department of Medicine-Hematology and Oncology, UH Cleveland Medical Center, Cleveland, USA., Brose MS; Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, USA., Farago AF; Department of Medicine, Massachusetts General Hospital, Boston, USA., Taylor M; The Knight Cancer Institute, Oregon Health & Science University, Portland, USA., Shaw AT; Department of Medicine, Massachusetts General Hospital, Boston, USA., Montez S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA., Smith S; Loxo Oncology, South San Francisco, USA., Tuch BB; Loxo Oncology, South San Francisco, USA., Ebata K; Loxo Oncology, South San Francisco, USA., Cruickshank S; Loxo Oncology, South San Francisco, USA., Cox MC; Loxo Oncology, South San Francisco, USA., Burris HA 3rd; Medical Oncology, Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, USA., Doebele RC; Department of Medicine, University of Colorado Cancer Center, Aurora, USA. |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Feb 01; Vol. 30 (2), pp. 325-331. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
